XML 58 R41.htm IDEA: XBRL DOCUMENT v3.20.2
STATEMENT OF CASH FLOWS
 9 Months Ended
Jan. 24, 2020
USD ($)
Sep. 30, 2020
USD ($)
Cash flows from operating activities:    
Net loss $ (928) $ (482,508)
Adjustments to reconcile net income to net cash used in operating activities:    
Trust income reinvested in Trust Account   (691,470)
Changes in operating assets and liabilities:    
Increase in accrued expenses 928  
Prepaid expenses   (386,229)
Accounts payable and accrued expenses   333,432
Net cash used in operating activities 0 (1,226,775)
Cash flows from investing activities:    
Principal Amount Deposited In Trust Account 600,000,000 690,000,000
Net cash used in investing activities   (689,348,000)
Cash flows from financing activities:    
Proceeds from sale of private placement warrants   15,050,000
Proceeds from sale of units   690,000,000
Payment of underwriters' discount   (13,800,000)
Payment of offering costs   (649,398)
Advances received from Promissory note   460,885
Repayment of advances received from Promissory note   (230,885)
Net cash provided by financing activities   690,830,602
Increase in cash during period 0 255,827
Cash at beginning of period 0 0
Cash at end of period 0 255,827
Supplemental Schedule of Non-Cash Financing Activities:    
Deferred underwriting compensation   24,150,000
Class A common stock subject to possible redemption   660,903,790
Offering costs paid by Sponsor in exchange for Founder Shares 25,000  
Deferred offering costs included in accrued expenses $ 10,000 $ 64,294